Cargando…
Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients
BACKGROUND: The identification of anaplastic lymphoma kinase (ALK) rearrangements is found in approximately 5% of non-small-cell lung cancers (NSCLCs). However, the development of liquid biopsies as a diagnostic tool is less developed in these cases. This study investigates the use of CTCs during tr...
Autores principales: | Provencio, Mariano, Pérez-Callejo, David, Torrente, María, Martin, Paloma, Calvo, Virginia, Gutiérrez, Lourdes, Franco, Fernando, Coronado, Maria José, Cruz-Bermúdez, Juan Luis, Ruiz-Valdepeñas, Asunción Martín, Cruz-Bermúdez, Alberto, Sánchez-Beato, Margarita, Romero, Atocha, García-Grande, Aránzazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601742/ https://www.ncbi.nlm.nih.gov/pubmed/28938646 http://dx.doi.org/10.18632/oncotarget.19722 |
Ejemplares similares
-
Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment
por: Provencio, Mariano, et al.
Publicado: (2017) -
PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2017) -
Next-generation sequencing to dynamically detect mechanisms of resistance to ALK inhibitors in ALK-positive NSCLC patients: a case report
por: Sánchez-Herrero, Estela, et al.
Publicado: (2020) -
Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients
por: Sánchez-Herrero, Estela, et al.
Publicado: (2020) -
Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients
por: Provencio, Mariano, et al.
Publicado: (2017)